Rocket Pharmaceuticals (RCKT) Earnings
|
Expand Research on RCKT
| Next EPS Date | 11/5/26 | EPS Growth Rate | +11.1% |
|---|---|---|---|
| Average EPS % Beat Rate | +5.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q326 | N/A | -$0.40 | N/A | N/A | $222.22K | N/A | N/A | N/A | ||
| 8/10/26 | Q226 | $1.08 | $1.02 | +$0.06 | N/A | $222.22K | N/A |  | | Details | |
| 5/7/26 |
Q126 | -$0.42 | -$0.40 | -$0.02 | N/A | N/A | N/A | | | Details | |
| 2/26/26 |
Q425 | -$0.38 | -$0.43 | +$0.05 | N/A | N/A | N/A | | | Details | |
| 11/6/25 |
Q325 | -$0.45 | -$0.49 | +$0.04 | N/A | $359.46K | N/A | | | Details | |
| 8/11/25 |
Q225 | N/A | -$0.56 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/8/25 |
Q125 | -$0.56 | -$0.59 | +$0.03 | N/A | $2.27M | N/A | | | Details | |
| 2/27/25 |
Q424 | -$0.62 | -$0.72 | +$0.10 | N/A | $28.46K | N/A | | | Details |
